Garder ma session ouverte ?
Expiré dans 
La session est expirée
Votre session a expiré. Pour votre sécurité, VWR vous a déconnecté.
Voulez-vous vous connecter à nouveau?
  • Résultats des produits
  • Critères
  • Fournisseur
  • Affiner fournisseurs
    Trier par:

Votre recherche pour:

Anticorps


511 493  les résultats ont été trouvés
Anticorps

Explorez notre sélection de premier choix d'anticorps conçus pour faire progresser la découverte scientifique dans divers environnements de laboratoire. Notre catalogue complet comprend des anticorps monoclonaux, polyclonaux et recombinants, chacun méticuleusement vérifié pour des applications telles que Western Blot, ELISA, ImmunoChimie et Cytométrie en Flux. Adaptez votre choix par symbole et nom d'antigène, réactivité, clonalité, conjugaison et espèce hôte pour correspondre parfaitement à vos besoins de recherche. Améliorez vos résultats expérimentaux avec nos anticorps de précision, optimisés pour l'exactitude et la fiabilité.


SearchPresentationType-HORIZONTAL
Choisissez parmi les options ci-dessous pour affiner votre recherche. Plusieurs sélections dans n'importe quel menu déroulant peuvent être effectuées. Cliquez sur OK pour mettre à jour vos résultats.
 
 
SearchResultCount:"511493"
  Vue liste Recherche Easy View Vue simple
Trier par:
 
 
 
 

Numéro de catalogue: (BOSSBS-5873R-CY3)

Fournisseur:  Bioss
Description:   CNDP1 (Carnosine dipeptidase 1) belongs to the M20 metalloprotease family and is expressed in the adult nervous central system. It catalyzes preferential hydrolysis of the beta-Ala-|-His dipeptide (carnosine), and also anserine, Xaa-|-His dipeptides and other dipeptides including homocarnosine.
UOM:  1 * 100 µl
Numéro de catalogue: (BOSSBS-2751R-A488)

Fournisseur:  Bioss
Description:   Aurora A plays a role in cell cycle regulation during anaphase and/or telophase, in relation to the function of the centrosome/spindle pole region during chromosome segregation. Aurora A plays a key role during tumor development and progression and is overexpressed in many human cancers including breast, ovarian and colorectal. Aurora A is viewed as a potential target for anticancer drug treatment.Aurora B is a mitotic protein kinase that phosphorylates histone H3 (probably on Serine 10), behaves as a chromosomal passenger protein, and may regulate several stages of mitosis such as centrosome separation, chromosome segregation and cytokinesis. It localizes to the inner centromere region from prophase to anaphase. The Aurora kinases, members of the Ser/Thr protein kinase family, associate with microtubules during chromosome movement and segregation. Aurora kinase C may play a part in organizing microtubules in relation to the function of the centrosome/spindle pole during mitosis. This protein is localized to centrosome from anaphase to cytokinesis. Expression is limited to testis in normal cells. Elevated expression levels are seen only in a subset of cancer cells such as HepG2, HuH7 and HeLa cells. Aurora-C expression is maximum at M phase.
UOM:  1 * 100 µl
Numéro de catalogue: (BOSSBS-10059R-A350)

Fournisseur:  Bioss
Description:   Core component of multiple SCF-like ECS (Elongin-Cullin 2/5-SOCS-box protein) E3 ubiquitin-protein ligase complexes, which mediate the ubiquitination and subsequent proteasomal degradation of target proteins. As a scaffold protein may contribute to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme. The functional specificity of the E3 ubiquitin-protein ligase complex depends on the variable substrate recognition component. ECS(SOCS1) seems to direct ubiquitination of JAk2. Seems to be involved poteosomal degradation of p53/TP53 stimulated by adenovirus E1B-55 kDa protein. May form a cell surface vasopressin receptor.
UOM:  1 * 100 µl
Numéro de catalogue: (BOSSBS-6539R-A647)

Fournisseur:  Bioss
Description:   Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis.
UOM:  1 * 100 µl
Numéro de catalogue: (BOSSBS-6539R-A555)

Fournisseur:  Bioss
Description:   Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis.
UOM:  1 * 100 µl
Numéro de catalogue: (BOSSBS-10058R-A750)

Fournisseur:  Bioss
Description:   Endopeptidase that degrades various components of the extracellular matrix, such as aggrecan and cartilage oligomeric matrix protein (comp), during development, haemostasis and pathological conditions (arthritic disease). May also play a role in neovascularization or angiogenesis. hydrolyses collagen type IV, laminin, nidogen, nascin-C isoform, fibronectin, and type I gelatin.
UOM:  1 * 100 µl
Numéro de catalogue: (BOSSBS-13742R-A750)

Fournisseur:  Bioss
Description:   Plays a role in a late step of leukocyte extravasation helping cells to overcome the endothelial basement membrane. Acts at the same site as, but independently of, PECAM1 (By similarity). Homophilic adhesion molecule, but these interactions may not be required for cell aggregation (By similarity).
UOM:  1 * 100 µl
Numéro de catalogue: (BOSSBS-13469R-A680)

Fournisseur:  Bioss
Description:   Heterotrimeric G proteins function to relay information from cell surface receptors to intracellular effectors. Each of a very broad range of receptors specifically detects an extracellular stimulus (i.e. a photon, pheromone, odorant, hormone or neurotransmitter), while the effectors (e.g. adenyl cyclase), which act to generate one or more intracellular messengers, are less numerous. In mammals, G protein alhfa, beta and gamma polypeptides are encoded by at least 16, 4 and 7 genes, respectively. Most interest in G proteins has been focused on their a subunits, since these proteins bind and hydrolyze GTP and most obviously regulate the activity of the best studied effectors. Evidence, however, has established an important regulatory role for the beta gamma subunits. It is becoming increasingly clear that different G protein complexes expressed in different tissues carry structurally distinct members of the gamma as well as the alhfa and beta subunits, and that preferential associations between members of subunit families increase G protein functional diversity.
UOM:  1 * 100 µl
Numéro de catalogue: (BOSSBS-1966R-A680)

Fournisseur:  Bioss
Description:   May catalyse the degradation of intercellular cohesive structures in the cornified layer of the skin in the continuous shedding of cells from the skin surface. Specific for amino acid residues with aromatic side chains in the P1 position. Cleaves insulin A chain at '14-Tyr-|-Gln-15' and insulin B chain at '6-Leu-|-Cys-7', '16-Tyr-|-Leu-17', '25-Phe-|-Tyr-26' and '26-Tyr-|-Thr-27'. Could play a role in the activation of precursors to inflammatory cytokines.
UOM:  1 * 100 µl
Numéro de catalogue: (BOSSBS-0501R-CY5.5)

Fournisseur:  Bioss
Description:   JNK1(MAPK8) is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various cell stimuli, and targets specific transcription factors, and thus mediates immediate-early gene expression in response to cell stimuli. The activation of this kinase by tumor-necrosis factor alpha (TNF-alpha) is found to be required for TNF-alpha induced apoptosis. This kinase is also involved in UV radiation induced apoptosis, which is thought to be related to cytochrome c-mediated cell death pathway. Studies of the mouse counterpart of this gene suggested that this kinase play a key role in T cell proliferation, apoptosis and differentiation. Four alternatively spliced transcript variants encoding distinct isoforms have been reported.JNK1 is activated by threonine and tyrosine phosphorylation by either of two dual specificity kinases, MAP2K4 and MAP2K7. The JNK pathway is critically involved in diabetes and levels are abnormally elevated in obesity. The cell-permeable JNK inhibitory peptide may have promise as a therapeutic agent for diabetes.
UOM:  1 * 100 µl
Numéro de catalogue: (BOSSBS-13469R-A750)

Fournisseur:  Bioss
Description:   Heterotrimeric G proteins function to relay information from cell surface receptors to intracellular effectors. Each of a very broad range of receptors specifically detects an extracellular stimulus (i.e. a photon, pheromone, odorant, hormone or neurotransmitter), while the effectors (e.g. adenyl cyclase), which act to generate one or more intracellular messengers, are less numerous. In mammals, G protein alhfa, beta and gamma polypeptides are encoded by at least 16, 4 and 7 genes, respectively. Most interest in G proteins has been focused on their a subunits, since these proteins bind and hydrolyze GTP and most obviously regulate the activity of the best studied effectors. Evidence, however, has established an important regulatory role for the beta gamma subunits. It is becoming increasingly clear that different G protein complexes expressed in different tissues carry structurally distinct members of the gamma as well as the alhfa and beta subunits, and that preferential associations between members of subunit families increase G protein functional diversity.
UOM:  1 * 100 µl
Fournisseur:  Bioss
Description:   Chemotactic activity for resting CD4, CD8 T-cells and eosinophils. Binds to CCR3 and CCR10 and induces calcium mobilisation in a dose-dependent manner.
UOM:  1 * 100 µl
Fournisseur:  Bioss
Description:   Suppressin, also known as DEAF1 is a transcription factor required for embryonic development. Suppressin contains one SAND domain and one C-terminal MYND-type zinc finger. It interacts with LMO4 and CLIM-2, suggesting that it plays a role mediating cell fate and embryonic pattern formation. Suppressin is expressed in a variety of tissues and localises to the nucleus. Several isoforms exist due to alternative splicing and, depending on the isoform, Suppressin is secreted in some cell types. Secreted Suppressin can function to inhibit cell proliferation, arresting cells in the G0 or G1 phase. Mutations in the gene encoding Suppressin may result in a growth advantage leading to the development and progression of neoplasia. This suggest that Supressin is a potential target for cancer therapy.
UOM:  1 * 100 µl

Fournisseur:  Bioworld Technology
Description:   Synthetic peptide, corresponding to amino acids 145-195 of Human Smad2.
UOM:  1 * 1 EA
Numéro de catalogue: (BWRLAP0402)

Fournisseur:  Bioworld Technology
Description:   Synthetic peptide, corresponding to amino acids 270-320 of Human MEK1.
UOM:  1 * 1 EA
Numéro de catalogue: (BWRLAP0694)

Fournisseur:  Bioworld Technology
Description:   Synthetic peptide, corresponding to the N-terminus of Human TRAF2.
UOM:  1 * 1 EA
Appel de prix
Le stock de cet article est limité mais peut être disponible dans un entrepôt proche de vous. Merci de vous assurer que vous êtes connecté sur le site afin que le stock disponible soit affiché. Si l'call est toujours affiché et vous avez besoin d'aide, s'il vous plaît appelez-nous au 016 385 011
Le stock de cet article est limité mais peut être disponible dans un entrepôt proche de vous. Merci de vous assurer que vous êtes connecté sur le site afin que le stock disponible soit affiché. Si l'call est toujours affiché et vous avez besoin d'aide, s'il vous plaît appelez-nous au 016 385 011
Ces articles ne peuvent être ajoutés au Panier. Veuillez contacter votre service client ou envoyer un e-mail à vwr.be@vwr.com
Une documentation supplémentaire peut être nécessaire pour l'achat de cet article. Un représentant de VWR vous contactera si nécessaire.
Ce produit a été bloqué par votre organisation. Contacter votre service d'achat pour plus d'informations.
Le produit original n'est plus disponible. Le remplacement représenté est disponible
Les produits marqués de ce symbole ne seront bientôt plus disponibles - vente jusqu'à épuisement de stock. Des alternatives peuvent être disponibles en recherchant le code article VWR indiqué ci-dessus. Si vous avez besoin d'une assistance supplémentaire, veuillez contacter notre Service Clientèle au 016 385 011.
8 945 - 8 960  de 511 493